Travoprost
Rank #285 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$41.5M
Total Cost
178,599
Total Claims
$41.5M
Total Cost
5,648
Prescribers
$232
Cost per Claim
26,548
Beneficiaries
313,467
30-Day Fills
$7,352
Avg Cost/Provider
32
Avg Claims/Provider
Share of Medicare Part D Spending
0.02%
of total Medicare Part D spending
$41.5M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $41.5M total
Top Prescribers of Travoprost
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Deborah Alexander | Ophthalmology | Weslaco, TX | 682 | $168K |
| 2 | Barbara Marsh | Ophthalmology | Albuquerque, NM | 375 | $85K |
| 3 | James Pasternack | Ophthalmology | Bloomfield, CT | 187 | $83K |
| 4 | David Gross | Ophthalmology | Merrillville, IN | 289 | $81K |
| 5 | Douglas Day | Ophthalmology | Atlanta, GA | 281 | $78K |
| 6 | Shawn Riley | Ophthalmology | Myrtle Beach, SC | 274 | $76K |
| 7 | Jacqueline Gabay | Ophthalmology | Elmwood Park, NJ | 296 | $74K |
| 8 | Howard Kushnick | Ophthalmology | Allentown, PA | 253 | $72K |
| 9 | Matthew Fabrizio | Ophthalmology | Atlanta, GA | 217 | $68K |
| 10 | Jorge Rivera | Ophthalmology | Mayaguez, PR | 493 | $65K |
| 11 | Kundandeep Nagi | Ophthalmology | San Antonio, TX | 254 | $62K |
| 12 | James Rouse | Ophthalmology | Knoxville, TN | 234 | $61K |
| 13 | Anthony Economou | Ophthalmology | Tulsa, OK | 227 | $61K |
| 14 | Fiaz Zaman | Ophthalmology | Houston, TX | 213 | $60K |
| 15 | Brian Francis | Ophthalmology | Fountain Valley, CA | 225 | $60K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 282 | Tadalafil (Tadalafil) | $42.3M | 91,082 |
| 283 | Topiramate (Topiramate) | $41.9M | 1,141,093 |
| 284 | Latanoprostene Bunod (Vyzulta) | $41.6M | 92,705 |
| 285 | Travoprost (Travoprost) | $41.5M | 178,599 |
| 286 | Alendronate Sodium (Alendronate Sodium) | $41.4M | 3,414,824 |
| 287 | Daptomycin (Daptomycin) | $41.2M | 41,245 |
| 288 | Pitavastatin Calcium (Livalo) | $40.8M | 69,636 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology